|
|||||
|
|
Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies |
|
| Authors: | W. J. Sandborn S. Danese G. D'Haens L. Moro R. Jones R. Bagin M. Huang E. David Ballard J. Masure S. Travis |
| Affiliation: | 1. University of California, San Diego, La Jolla, CA, USA;2. Instituto Clinico Humanitas, Milan, Italy;3. Academic Medical Center, Amsterdam, The Netherlands;4. Cosmo Technologies Ltd., Dublin, Ireland;5. Santarus, Inc., San Diego, CA, USA;6. Ferring Pharmaceuticals, St. Prex, Switzerland;7. Translational Gastroenterology Unit, Oxford University Hospitals, Oxford, UK |
| Abstract: | |
| Keywords: | |